-
1por Fortin, Anny, Caridha, Diana P., Leed, Susan, Ngundam, Franklyn, Sena, Jenell, Bosschaerts, Tom, Parriott, Sandi, Hickman, Mark R., Hudson, Thomas H., Grogl, Max“…CONCLUSIONS/SIGNIFICANCE: Given the data showing the outstanding efficacy and tolerability of OlPC, our results suggest that OlPC is a promising new drug candidate to improve and simplify current clinical management of L. major CL.…”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2por Sonzogni-Desautels, Karine, Renteria, Axel E., Camargo, Fabio V., Di Lenardo, Thomas Z., Mikhail, Alexandre, Arrowood, Michael J., Fortin, Anny, Ndao, Momar“…Oral treatments, with OlPC, miltefosine, paromomycin or PBS, began on Day 3 post-infection for 10 days. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3por Shio, Marina Temi, Paquet, Marilene, Martel, Caroline, Bosschaerts, Tom, Stienstra, Stef, Olivier, Martin, Fortin, Anny“…The selected drug is oleylphosphocholine (OlPC) formulated as liposomes, particles known to be prone to macrophage ingestion. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto